INQUIRER.net USA on MSN1h
Leen Kawas on AI and drug discovery: The ethical challenges that will define the next decadeDisclaimer: This article is intended for US audiences] In the biotechnology sector, artificial intelligence (AI) has emerged as a transformative force with profound implications for drug discovery and ...
A bankruptcy filing Sunday by 23andMe, a genetic testing and biotechnology company, is shining light on what could happen to ...
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
The global average for countries to report genetic information about bird flu, crucial to tracking and preventing a human ...
Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced that an ...
Neurosurgeon Alan Chiang, MD, has joined the board of directors for clinical-stage medical biotechnology company NeOnc ...
Me recently filed for bankruptcy. Here's how users can download and delete their data from the platform ahead of the sale.
DNA genetics testing company 23andMe has filed for Chapter 11 bankruptcy. It emphasizes there will be uninterrupted service ...
The company saw its DNA data as an engine that would revolutionize drug discovery and medical care, but it never found a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback